Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Hybrigenics

Hybrigenics

General
Jobs • 0
Shortlists/Awards • 3
Pricing strategy • 0
Partners/Competitors • 38
Last update: Dec 6, 2024 Last update: Dec 6, 2024
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:France
Organization type:Consulting organization
Funding agencies:Other, Horizon 2020, USDA, Horizon Europe
 Other, Horizon 2020 (2014 - 2020), United States Department of Agriculture, Horizon Europe (2021 - 2027)
Sectors:Health, Research
 Health, Research
Sanctions:Check now
Status:
Active

Attachments • 0

About

Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.

Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.

Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.

 

Awards

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.
Learn more about our membership benefits